Hospital Israelita Albert Einstein announced this Tuesday (6) the construction of an advanced oncology and hematology center with investments of around R$ 1.2 billion, R$ 400 million of which from Einstein and R$ 800 million from Grupo Bueno Netto and investment funds.
The start of works is scheduled for April 2023 and the end for 2025. The center will combine research and assistance in oncology, focusing on prevention, diagnosis, treatment, rehabilitation and support after treatment in aspects such as physical, psychosocial, emotional and spiritual (“survival”).
Located in Parque Global, a planned neighborhood that is being built between Cidade Jardim and Burle Marx Park, in the south zone of the capital of São Paulo, the project arrives with the goal of placing Einstein among the ten best in the world in cancer care in five years old.
Today, the institution ranks 16th, being the first in Latin America, according to the World’s Best Specialized Hospitals 2023, ranking by the North American magazine Newsweek.
According to Sidney Klajner, president of Einstein, the idea is to concentrate in the new center all oncological research and assistance carried out at the Einstein unit in Morumbi, in the south zone, and to increase the number of new cases treated by 10 thousand.
Currently, more than 25,000 people are assisted by the Einstein’s oncology units, which are also located at Hospital Municipal Vila Santa Catarina and Hospital de Goiânia. There are more than 650 professionals involved in care and international partnerships with organizations such as MD Anderson, City of Hope and John Hopkins. The hospital has partnerships with SUS in oncology teleconsultations.
“Given the perspective of an increase in oncological diseases, we see the opportunity not only to expand the capacity of care, but to bring to the same environment a hospital that will have its share of cutting-edge research in the prevention and early detection of cancer, in addition to of assistance based on the most modern equipment and knowledge”, explains Klajner.
According to a recent report by Inca (National Cancer Institute), from 2023 to 2025, Brazil will have 704,000 new cases of cancer each year. The estimate results in more than 2 million new diagnoses of the disease in the next three years. Experts in the area argue that a review of public policies in the area is urgent.
The new oncology center will occupy an area of 38,000 m², with ten operating rooms, one of which is a hybrid room and two robotic surgery rooms, 160 beds, 20 ICUs, 20 semi-intensive, 120 medical-surgical clinics, 84 offices, 36 chemotherapy and 15 laboratory stations.
It will also have an image-guided intervention system, magnetic resonance imaging, computed tomography, PETs CT (one of the most accurate tests for detecting cancer), linear accelerators and a blood bank. There will also be an oncology emergency room for 12,000 people a year.
One of the highlights of the new venture, according to Klajner, is personalized medicine, which includes genetic sequencing, artificial intelligence and cell therapy and which has radically changed the treatment of cancer.
“Each tumor has a unique signature and personalized therapies can be created individually, with drugs that use specific markers in cancer cells or even re-educate the immune system”, he explains.
According to Klajner, technological and knowledge evolution has made most cancers or hematologic diseases curable, but early detection remains the biggest challenge. “The cure outcome and the cost for it is based on early detection and, mainly, on personalized medicine.”
This means that through genetic sequencing it is possible both to choose the most appropriate treatment for the patient, avoiding random therapies and changes when they fail, and to act in the detection of increased risk for certain tumors.
“It may seem very expensive for us to talk about genomics today, but it is what will allow you, in the future, to treat early disease more cheaply and with better outcomes than late diagnosis.”
According to Adalberto Bueno Netto, president of Grupo Bueno Netto, responsible for the construction of Parque Global in partnership with Related Group, the arrival of Einstein in the new planned neighborhood will create something innovative.
The structure of the Einstein will be built in an innovation, health and education complex, which will have a medical office building and a hotel.
Parque Global is being built on a 218,000 m² plot of land on the Pinheiros waterfront, with 40,000 m² occupied by the residential area with five towers of 47 floors each and a shopping center and more than 40,000 square meters of residential area.
With a PSV (Potential Sales Value) of R$11.5 billion, it is considered the largest real estate project under development in Latin America. It was the first real estate project in the country to have access to an exclusive Santander line of financing for sustainable projects.
One of the great differentials of the development is the landscaping, made up exclusively of native species from the Atlantic Forest that connects to the surrounding green areas.
The new neighborhood project also provides for the execution of three new local lanes on the Pinheiros waterfront along the entire length of the land and provision for interconnection with a station on the 17-gold subway line.
Parque Global is also responsible for the consortium that is implementing the Parque Linear Bruno Covas, a 17 km long project that is recovering the west bank of the Pinheiros River.
Structure of the new oncology center at Einstein
Area: 38 thousand m²
Operating rooms: 10, one hybrid room and two robotic surgery rooms
Beds: 160 automated beds
ICUs: 20
Semi-intensive units: 20
Surgical medical clinics: 120
Offices: 84
Chemotherapy rooms: 36
Laboratory stations: 15
I have over 8 years of experience in the news industry. I have worked for various news websites and have also written for a few news agencies. I mostly cover healthcare news, but I am also interested in other topics such as politics, business, and entertainment. In my free time, I enjoy writing fiction and spending time with my family and friends.
